Studies suggest that its effects on PPAR-γ may reduce lipid accumulation and improve metabolic parameters under certain conditions, such as obesity and hyperlipidemia [83]. This evidence concerns the gene PPARG and obesity due to melanocortin 4 receptor deficiency.